順天堂大学医学部附属静岡病院は、静岡県伊豆の国市長岡1129にある医療機関。学校法人順天堂が運営する病院である。旧称は順天堂大学医学部附属伊豆長岡病院。総合周産期母子医療センター、肝疾患診療連携拠点病院などを有し、静岡県東部の基幹病院と位置づけられている。

During the past decade, Juntendo University Shizuoka Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Juntendo University Shizuoka Hospital" #1 sponsor was "Gilead Sciences" with 3 trials, followed by "Chugai Pharmaceutical" with 2 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "Associations for Establishment of Evidence in Interventions" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Juntendo University Shizuoka Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Niigata University Medical & Dental Hospital" with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Brightech International" with 1 trials as a collaborator and "EPS International" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Juntendo University Shizuoka Hospital" are "Gastrointestinal Stromal Tumor" (2 trials), "Metastatic Cancer" (2 trials), "Nonalcoholic Steatohepatitis" (2 trials), "Acute Heart Failure" (1 trials) and "Arrhythmias, Cardiac" (1 trials). Many other conditions were trialed in "Juntendo University Shizuoka Hospital" in a lesser frequency.

Most popular intervention types in "Juntendo University Shizuoka Hospital" are "Drug" (11 trials), "Device" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Placebo to match SEL 18 mg" (2 trials), "Placebo to match SEL 6 mg" (2 trials), "SEL" (2 trials) and "Anagrelide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Juntendo University Shizuoka Hospital" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Juntendo University Shizuoka Hospital". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Juntendo University Shizuoka Hospital, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Juntendo University Shizuoka Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".